XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
7.51
-0.06 (-0.79%)
Oct 22, 2024, 4:00 PM EDT - Market closed
XBiotech Market Cap
XBiotech has a market cap or net worth of $228.78 million as of October 23, 2024. Its market cap has increased by 83.32% in one year.
Market Cap
228.78M
Enterprise Value
50.25M
1-Year Change
83.32%
Ranking
Category
Stock Price
$7.51
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $228.78M, a decrease of -68.98%. That is a compound annual growth rate of -11.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 230.60M | 89.48% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biodesix | 233.74M |
| Cybin | 232.22M |
| Inhibrx Biosciences | 231.61M |
| Nanobiotix | 230.61M |
| Utah Medical Products | 230.53M |
| aTyr Pharma | 226.63M |
| scPharmaceuticals | 226.63M |
| Trevi Therapeutics | 226.49M |